Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow, the researchers wrote
In one trial of nearly 2,000 adults with obesity, but not type 2 diabetes, those taking 2.4 mg of semaglutide (a typical maintenance dosage for Wegovy) lost nearly 15% of their body weight in about a year and a half
Aiming for 1.2 to 1.6 grams per kilogram of your body weight is a good starting point but dont forget to consider your activity level and the quality of the protein youre consuming
Selecting an appropriate peptides source becomes vital when results and quality count
GLP-1s have already demonstrated a track record of safety and mortality reduction that can benefit a large percentage of the population, many of whom have a substance use disorder
Amylin seems to reduce the amount of food people eat by signaling a sense of fullness to the brain